Article
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.
Blood - 15 Oct 2008
O'Shea Derville, O'Riain Ciarán, Taylor Claire, Waters Rachel, Carlotti Emanuela, Macdougall Finlay, Gribben John, Rosenwald Andreas, Ott German, Rimsza Lisa M, Smeland Erlend B, Johnson Nathalie, Campo Elias, Greiner Timothy C, Chan Wing C, Gascoyne Randy D, Wright George, Staudt Louis M, Lister T Andrew, Fitzgibbon Jude
Abstract excerpt
The International Prognostic Index and the Follicular Lymphoma International Prognostic Index are widely used for the risk assessment of follicular lymphoma (FL). Although molecular studies have provided insight into the biology of FL, no molecular marker has impacted on treatment stratification....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.